AIP vs. NVEC, TGAN, VLN, VPG, AAOI, CAN, MX, QUIK, SKYT, and AXTI
Should you be buying Arteris stock or one of its competitors? The main competitors of Arteris include NVE (NVEC), Transphorm (TGAN), Valens Semiconductor (VLN), Vishay Precision Group (VPG), Applied Optoelectronics (AAOI), Canaan (CAN), Magnachip Semiconductor (MX), QuickLogic (QUIK), SkyWater Technology (SKYT), and AXT (AXTI). These companies are all part of the "computer and technology" sector.
Arteris (NASDAQ:AIP) and NVE (NASDAQ:NVEC) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, community ranking, earnings, dividends, media sentiment, risk and analyst recommendations.
NVE has lower revenue, but higher earnings than Arteris. Arteris is trading at a lower price-to-earnings ratio than NVE, indicating that it is currently the more affordable of the two stocks.
NVE received 189 more outperform votes than Arteris when rated by MarketBeat users. However, 57.69% of users gave Arteris an outperform vote while only 56.98% of users gave NVE an outperform vote.
In the previous week, Arteris had 7 more articles in the media than NVE. MarketBeat recorded 8 mentions for Arteris and 1 mentions for NVE. Arteris' average media sentiment score of 0.52 beat NVE's score of 0.00 indicating that Arteris is being referred to more favorably in the media.
NVE has a net margin of 57.46% compared to Arteris' net margin of -69.70%. NVE's return on equity of 25.83% beat Arteris' return on equity.
64.4% of Arteris shares are owned by institutional investors. Comparatively, 66.0% of NVE shares are owned by institutional investors. 33.7% of Arteris shares are owned by insiders. Comparatively, 2.0% of NVE shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Arteris has a beta of 1.04, indicating that its share price is 4% more volatile than the S&P 500. Comparatively, NVE has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500.
Arteris presently has a consensus price target of $13.40, suggesting a potential upside of 64.62%. Given Arteris' higher possible upside, equities research analysts clearly believe Arteris is more favorable than NVE.
Summary
NVE beats Arteris on 10 of the 17 factors compared between the two stocks.
Get Arteris News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIP and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AIP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
